|
 |
ciprofloxacin hydrochlorideThis page contains recent news articles, when available, and an overview of ciprofloxacin hydrochloride but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: ciprofloxacin hydrochloride (when available) Ciprofloxacin, a broad-spectrum antiinfective agent of the fluoroquinolone class, is used to treat gram-negative infections, sexually transmitted diseases, mycobacterial infections, corneal ulcers, and bacterial conjunctivitis. For the treatment of Bacterial infection of Respiratory tract, UTI, Uncomplicated Cystitis in females, GI, Chronic Bacterial Prostatitis, CNS, Immuno compromised patients, Skin, Bone and Joint Infections, Uncomplicated cervical and urethral gonorrhea Mechanism Of Action: Ciprofloxacin has in vitro activity against a wide range of gram-negative and gram-positive organisms. Ciprofloxacin inhibits bacterial DNA gyrase, an enzyme responsible for counteracting excessive supercoiling of DNA during replication or transcription. The mechanism of action of quinolones, including ciprofloxacin, is different from that of other antimicrobial agents such as beta-lactams, macrolides, tetracyclines, or aminoglycosides; therefore, organisms resistant to these drugs may be susceptible to ciprofloxacin. There is no known cross-resistance between ciprofloxacin and other classes of antimicrobials. News Articles on Ciprofloxacin … District Court Opinions - IN RE CIPROFLOXACIN HYDROCHLORIDE … - Mar 31, 2005 IN RE CIPROFLOXACIN HYDROCHLORIDE ANTITRUST LITIGATION. No. 1:00-MDL-1383DGT. United States District Court, E.D. New York. March 31, 2005. ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Depomed and Watson Expand ProQuin(R) XR Promotion Agreement to … - Sep 25, 2007 Proquin[R] XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary ... Free with registration - Business Wire - AccessMyLibrary.com … , atomic absorption spectrometric and spectrophotometric determinati... - Mar 1, 2005 The present study includes new direct and indirect methods for determination of amifloxacin, ciprofloxacin hydrochloride, difloxacin hydrochloride, ... Free with registration - American Journal of Applied Sciences - AccessMyLibrary.com Depomed Enters into Promotion Agreement with Watson for ProQuin(R) … - Jul 23, 2007 ProQuin([R]) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated ... $4.95 - Business Wire - ECNext Drug Development; US FDA accepts Indian company's drug master file … - Jan 3, 2005 Ciprofloxacin hydrochloride is an antibacterial molecule that had gone off patent in the US earlier this year. JBCPL will be the third Indian company having ... Pay-Per-View - Biotech Business Week - Factiva, from Dow Jones Depomed and Esprit Announce Availability of ProQuin(R)XR 3-Tablet … - Apr 26, 2006 ProQuin(R)XR is a once-daily prolonged-release formulation of ciprofloxacin hydrochloride approved to treat uncomplicated urinary tract infections (UTIs). ... Genetic Engineering News - Genetic Engineering News (press release) Herbal antidotes for food poisoning, snake venom - Dec 25, 2008 The researchers compared the adsorptive potential of Garcinia kola seed (GKS) for ciprofloxacin hydrochloride (CIP) with that of a standard adsorbent and a ... Guardian - Nigeria - The Guardian - Nigeria Drug Development; US FDA accepts Indian company's drug master file … - Jan 9, 2005 Ciprofloxacin hydrochloride is an antibacterial molecule that had gone off patent in the US earlier this year. JBCPL will be the third Indian company having ... Pay-Per-View - Medical Letter on the CDC & FDA - Factiva, from Dow Jones Depomed and Madaus Srl Announce Acceptance of the Application for … - Mar 29, 2006 ProQuin(R) XR (ciprofloxacin hydrochloride) once daily, extended-release tablets have been approved by the FDA for the treatment of uncomplicated urinary ... Free with registration - Business Wire - AccessMyLibrary.com Wisconsin Case Law - MEYERS v. BAYER, 2007 WI 99 - Jul 13, 2007 See In re Ciprofloxacin Hydrochloride Antitrust Litig., 166 F. Supp. 2d 740, 742-43 (E.D.N.Y. 2001). ¶ 17. On remand of the matter back to the Milwaukee ... Pay-Per-View - Wisconsin Case Law - Loislaw United States Federal Circuit Court of Appeals Reports - IN RE … - Dec 23, 2008 2008) In re CIPROFLOXACIN HYDROCHLORIDE ANTITRUST LITIGATION. ... More particularly, the patent is directed to ciprofloxacin hydrochloride, the compound ... Pay-Per-View - United States Federal Circuit Court of... - Loislaw Depomed Receives FDA Approval of Proquin XR for Uncomplicated … - May 20, 2005 Once daily Proquin(TM) XR (ciprofloxacin hydrochloride) extended-release tablets for the treatment of uncomplicated urinary tract infections has been ... RedOrbit Barbara A. Meyers, Lynn Stucker, Loyal - May 9, 2006 See In re Ciprofloxacin Hydrochloride Antitrust Litig., 363 F. Supp. 2d 514, 518 (EDNY 2005). Barr answered the complaint and asserted counterclaims based ... WisBar - WisBar United States: Cash Payments To Settle Hatch-Waxman Litigation Do Not... - Jan 12, 2008 In re Ciprofloxacin Hydrochloride Antitrust Litigation, Case Nos. 08-1907 (Fed. Cir., Oct. 15, 2008) (Prost, J.). Bayer owns a patent directed to compounds ... Mondaq News Alerts - Mondaq News Alerts (Registration) Meyers v. Bayer AG, 735 NW2d 448, 303 Wis.2d 295, 2007 WI 99 (Wis. … - Jul 13, 2007 See In re Ciprofloxacin Hydrochloride Antitrust Litig., 363 F. Supp. 2d 514 (E.D.N.Y. 2005). [125], ¶84 The case now before us was filed in state court, ... $2.95 - Wisconsin Supreme Court - VersusLaw Article: The effect of natural sunlight on ciprofloxacin ophthalmic... - Oct 1, 2005 The chromatographic separation of ciprofloxacin hydrochloride was ... Chromatographia (LC Assay for Ciprofloxacin Hydrochloride Ophthalmic Solution. ... Pay-Per-View - Journal of the Mississippi Academy of... - HighBeam Research The Federal Circuit Cipro Decision: Another Blow To The FTC's Fight … - Oct 17, 2008 2 Id. at 2 (citing to In re Ciprofloxacin Hydrochloride Antitrust Litig. 363 F. Supp. 2d 514 (E.D.N.Y. 2005)). 3 The plaintiffs also brought a state law ... $9.94 - Mondaq Business Briefing - Alacra Store Depomed and Esprit Enter into License Agreement for Proquin(TM) XR; … - Jul 28, 2005 Proquin(TM) XR (ciprofloxacin hydrochloride) once daily, extended-release tablets have been approved by the FDA for the treatment of uncomplicated urinary ... $4.95 - Business Wire - ECNext Cash Payments To Settle Hatch-Waxman Litigation Do Not Violate … - Dec 1, 2008 In re Ciprofloxacin Hydrochloride Antitrust Litigation, Case Nos. 08-1907 (Fed. Cir., Oct. 15, 2008) (Prost, J.). Bayer owns a patent directed to compounds ... $9.94 - Mondaq Business Briefing - Alacra Store Chemicals & Pharmaceuticals Ltd. US FDA accepts Indian company's … - Jan 5, 2005 Ciprofloxacin hydrochloride is an antibacterial molecule that had gone off patent in the US earlier this year. JBCPL will be the third Indian company having ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones FDA gets Bayer to drop animal antibiotic Company disagrees with … - Sep 10, 2005 ...and turkeys was especially worrisome because the drug is a fluoroquinolone, in the same family of antibiotics as Cipro (ciprofloxacin hydrochloride). ... Pay-Per-View - The Advocate - ProQuest Archiver Monday's Health Winners & Losers - Jul 23, 2007 ...an agreement to co-promote ProQuin XR, the extended-release formulation of ciprofloxacin hydrochloride to treat uncomplicated urinary tract infections. ... TheStreet.com - TheStreet.com (subscription) Depomed Announces Equity Financing Commitment of Up to $30 Million - Dec 12, 2006 ProQuin(R) XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary ... Genetic Engineering News - Genetic Engineering News (press release) Depomed Settles Patent Litigation Against IVAX - Apr 7, 2008 Proquin(R) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary ... Genetic Engineering News - Genetic Engineering News (press release) Depomed Delivers Notice of Breach and Demand for Arbitration to... - Dec 18, 2006 ProQuin([R]) XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary ... Free with registration - Business Wire - AccessMyLibrary.com Court Grants Depomed's Motion for Summary Judgment of Patent … - Dec 13, 2007 ProQuin([R]) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated ... Free with registration - Business Wire - AccessMyLibrary.com Depomed Receives $10 Million License Fee from Esprit and Withdraws … - Dec 21, 2006 ProQuin([R]) XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary ... Free with registration - Business Wire - AccessMyLibrary.com Depomed to Announce Third Quarter 2007 Financial Results on … - Nov 1, 2007 ProQuin ® XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary ... businesswire.com Ending Battle With FDA, Bayer Withdraws Poultry Antibiotic - Sep 9, 2005 ...and turkeys was especially worrisome because the drug is a fluoroquinolone, in the same family of antibiotics as Cipro (ciprofloxacin hydrochloride). ... Washington Post OTCPicks.com Stocks to Watch for Friday, November 21st DEPO - Nov 21, 2008 Proquin® XR (ciprofloxacin hydrochloride) is approved in the United States for the once-daily treatment of uncomplicated urinary tract infections and is ... TransWorldNews - TransWorldNews (press release) Depomed Reports 2006 Year End Financial Results - Mar 14, 2007 Of the total revenue recognized in 2006, $1.3 million was in product sales revenue from the commercial supply of ProQuin(R) XR (ciprofloxacin hydrochloride) ... Genetic Engineering News - Genetic Engineering News (press release) Depomed Completes $20 Million Registered Direct Offering - Apr 23, 2007 ProQuin(R) XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary ... Genetic Engineering News - Genetic Engineering News (press release) Depomed and King Pharmaceuticals Prepare for Launch of Glumetza(TM … - Aug 23, 2006 ProQuin(R) XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary ... Free with registration - Business Wire - AccessMyLibrary.com Really, Don't Drink the Water - Jul 26, 2005 Remedies include the tried-and-true Pepto-Bismol; ciprofloxacin hydrochloride (brand name Cipro), a prescription antibiotic; and Xifaxan, ... New York Times Depomed Says FDA Approves 1000 mg Strength Tablets of Glumetza - Jan 2, 2008 ProQuin® XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary ... FierceBiotech Merger and Acquisition Scenario - May 20, 2006 Falcon Ofloxacin; Ciloxan (Ciprofloxacin Hydrochloride). Ocular Infections. Aminoglycosides. Therapeutics that treat. $250.00 - Revere Reports - Revere Niferex-150 Forte Oral : Uses, Side Effects, Interactions, Pictures, ... - Feb 4, 2005 Cipro (ciprofloxacin hydrochloride) US prescribing information. Bayer Corporation October, 2008. 2.Penetrex (enoxacin) US prescribing information. ... WebMD Santarus and Depomed Announce US Promotion Agreement for … - Jul 22, 2008 ProQuin(R) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary ... RedOrbit Merger and Acquisition Scenario - May 20, 2006 Falcon Ofloxacin; Ciloxan (Ciprofloxacin Hydrochloride). Ocular Infections. Aminoglycosides. Therapeutics that treat bacterial infections of the eye by ... $250.00 - Revere Reports - Revere United States 11th Circuit Court of Appeals Reports - SCHERING- … - Mar 8, 2005 See In re Ciprofloxacin Hydrochloride Antitrust Litigation, 261 F.Supp.2d 188, 251 (EDNY 2003). Hatch-Waxman essentially redistributes the relative risk ... Pay-Per-View - United States 11th Circuit Court of... - Loislaw Depomed Announces Retirement of Chief Financial Officer John F. … - Oct 11, 2007 Proquin([R]) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated ... $4.95 - Business Wire - ECNext Merger and Acquisition Scenario - Mar 22, 2006 Falcon Ofloxacin; Ciloxan (Ciprofloxacin Hydrochloride). Ocular Infections. Aminoglycosides. Therapeutics that treat bacterial infections of the eye by ... $250.00 - Revere Reports - Revere WHO expert committee on specifications for pharmaceutical preparations... - Aug 1, 2005 9930250 cimetidine 100mg 190150 9930256 ciprofloxacin hydrochloride 400mg 197210 9930252 ciprofloxacin by-compound A 20mg 198220 9930253 ciprofloxacin ... Free with registration - Technical Report Series - AccessMyLibrary.com Depomed Files Prior Approval Supplement for 1000 Mg Strength Tablets ... - Apr 2, 2007 ProQuin® XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary ... RedOrbit Depomed Reports Positive Efficacy Data From a Phase 2 Trial of … - Feb 12, 2008 Proquin(R) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily. Lifescience-online Schering-Plough Corp. v. Federal Trade Commission, 402 F.3d 1056, 74 ... - Mar 8, 2005 See In re Ciprofloxacin Hydrochloride Antitrust Litigation, 261 F.Supp.2d 188, 251 (E.D.N.Y. 2003). HatchWaxman essentially redistributes the relative risk ... $2.95 - U.S. Court of Appeals, Eleventh Circuit - VersusLaw Depomed Announces Sweeping Interim Victory in Litigation against Ivax - Dec 20, 2006 ProQuin(R) XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary ... Genetic Engineering News - Genetic Engineering News (press release) Depomed Announces Results of Phase 3 Clinical Trial for Gabapentin GR... - Jul 10, 2007 ProQuin([R]) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated ... Free with registration - Business Wire - AccessMyLibrary.com Depomed Initiates Second Phase 3 Trial in Menopausal Hot Flashes - Oct 20, 2008 Proquin(R) XR (ciprofloxacin hydrochloride) is approved in the United States for the once-daily treatment of uncomplicated urinary tract infections and is ... Lifescience-online Depomed to Present at the UBS Global Life Sciences Conference - Sep 20, 2006 ProQuin(R) XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary ... RedOrbit Depomed Secures $15 Million in Non-Dilutive Funding for Hot Flash … - Jun 30, 2008 Proquin(R) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary ... Genetic Engineering News - Genetic Engineering News (press release) Depomed to Present at the Acumen BioFin Rodman & Renshaw 9th … - Oct 30, 2007 Proquin([R]) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated ... Free with registration - Business Wire - AccessMyLibrary.com Depomed Reports Second Quarter 2006 Financial Results; Revenues … - Aug 7, 2006 ProQuin(R) XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary ... Free with registration - Business Wire - AccessMyLibrary.com Making sense of drug safety - Dec 6, 2005 The first paragraph of the first section, "Description," contains this gem: "Ciprofloxacin hydrochloride, USP, a fluoroquinolone, is the monohydrochloride ... Washington Times Covidien and Depomed Announce License Agreement - Nov 24, 2008 Proquin ® XR (ciprofloxacin hydrochloride) is approved in the United States for the once-daily treatment of uncomplicated urinary tract infections and is ... Genetic Engineering News - Genetic Engineering News (press release) Depomed to Present at the 6th Annual Needham & Company … - Jun 8, 2007 ProQuin(R) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary ... Genetic Engineering News - Genetic Engineering News (press release) Depomed to Present at the Thomas Weisel Partners Healthcare … - Aug 31, 2006 ProQuin(R) XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary ... Free with registration - Business Wire - AccessMyLibrary.com Depomed, Inc. (DEPO) Doses First Patient in New Phase 3 Clinical... - Mar 24, 2008 ProQuin® XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary ... Lifescience-online Overhaul of unwieldy labels on drugs isn't thorough enough - Dec 4, 2005 The first paragraph of the first section, ``Description,'' contains this gem: ``Ciprofloxacin hydrochloride, USP, a fluoroquinolone, ... Pay-Per-View - San Jose Mercury News - Factiva, from Dow Jones Depomed to Present at the CIBC World Markets Annual Biotechnology … - Apr 4, 2007 ProQuin([R]) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated ... Free with registration - Business Wire - AccessMyLibrary.com Depomed Obtains Exclusive License to Gabapentin Use in Hot Flashes. - Oct 18, 2006 ProQuin[R] XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary ... Free with registration - Business Wire - AccessMyLibrary.com Depomed to Present at the UBS Global Life Sciences Conference - Sep 18, 2008 Proquin(R) XR (ciprofloxacin hydrochloride extended release tablets) is approved in the United States for the once-daily treatment of uncomplicated urinary ... RedOrbit Depomed, Biovail Revise Partnership Agreement for Development, … - Dec 13, 2005 Proquin ® XR (ciprofloxacin hydrochloride) once daily, extended-release tablets have been approved by the FDA for the treatment of uncomplicated urinary ... ccnmatthews.com Depomed Announces Strong Positive Phase II Trial Results for Once … - Dec 12, 2006 ProQuin[R] XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary ... Free with registration - Business Wire - AccessMyLibrary.com Depomed Completes Patient Enrollment in Phase 3 Clinical Trial of … - Mar 8, 2007 ProQuin([R]) XR (ciprofloxacin hydrochloride) extended release tablets have been approved by the FDA for the once-daily treatment of uncomplicated urinary ... Free with registration - Business Wire - AccessMyLibrary.com Depomed Files Investigational New Drug Application for Gabapentin GR ... - Mar 12, 2007 ProQuin([R]) XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once-daily treatment of uncomplicated urinary ... Free with registration - Business Wire - AccessMyLibrary.com Depomed to Announce Third Quarter 2006 Financial Results on Thursday … - Nov 9, 2006 ProQuin(R) XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary ... Genetic Engineering News - Genetic Engineering News (press release) Depomed Completes Enrollment in Phase II Clinical Trial in Diabetic … - Oct 5, 2006 ProQuin® XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary tract ... RedOrbit Depomed Doses First Patient In New Phase 3 Clinical Trial Of … - Mar 27, 2008 ProQuin® XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary ... Medical News Today - Medical News Today (press release) IN RE TERAZOSIN HYDROCHLORIDE ANTITRUST LITIGATION, 352 F. … - Jan 5, 2005 ...see also In re Ciprofloxacin Hydrochloride Antitrust Litig., 261 F. Supp. 2d 188, 242-43 (E.D.N.Y. 2003) (relying on the fact that the parties' settlement ... $2.95 - U.S. District Courts - VersusLaw Depomed Appoints James A. Schoeneck to Board of Directors. - Dec 12, 2007 ProQuin([R]) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated ... Free with registration - Business Wire - AccessMyLibrary.com Depomed Names Michael Sweeney Vice President of Product … - Dec 3, 2007 ProQuin(R) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary ... Genetic Engineering News - Genetic Engineering News (press release) Depomed to Present at the Rodman & Renshaw Acumen BioFin 4th … - Apr 30, 2007 ProQuin(R) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary ... Genetic Engineering News - Genetic Engineering News (press release) Depomed to Announce Fourth Quarter and Year End 2006 Financial … - Feb 28, 2007 ProQuin(R) XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary ... Genetic Engineering News - Genetic Engineering News (press release) Depomed Initiates Phase 3 Program In Menopausal Hot Flashes - Sep 19, 2008 Proquin® XR (ciprofloxacin hydrochloride extended release tablets) is approved in the United States for the once-daily treatment of uncomplicated urinary ... Medical News Today - Medical News Today (press release) Depomed Appoints David Zenoff to Board of Directors - Mar 23, 2007 ProQuin(R) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary ... Genetic Engineering News - Genetic Engineering News (press release) Depomed Signs $395M Deal with Solvay for Phase III Pain Drug - Nov 24, 2008 Depomed's pipeline also includes the approved antibiotic Proquin XR (ciprofloxacin hydrochloride extended-release tablets), which is marketed by Watson ... BioWorld Online - BioWorld Online Depomed Comments on Today's Trading Activity. - Dec 5, 2006 ProQuin[R] XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary ... Free with registration - Business Wire - AccessMyLibrary.com Depomed to Announce Second Quarter 2007 Financial Results on … - Aug 1, 2007 ProQuin(R) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary ... Genetic Engineering News - Genetic Engineering News (press release) Depomed Reports First Quarter 2007 Financial Results - May 8, 2007 ProQuin(R) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary ... Genetic Engineering News - Genetic Engineering News (press release) Depomed to Present at the Oppenheimer Diabetes Conference - Sep 18, 2006 ProQuin(R) XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary ... Genetic Engineering News - Genetic Engineering News (press release) Depomed Announces Reduction in Force. - Sep 17, 2007 Proquin([R]) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated ... Free with registration - Business Wire - AccessMyLibrary.com Press Release: Depomed Inc. Receives Progressive Follow. - M2 … - Jan 2, 2008 ProQuin XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary ... Pay-Per-View - M2 Presswire - HighBeam Research Press Release: Depomed Delivers Notice of Breach and Demand for … - Dec 17, 2006 ProQuin(R) XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary ... FierceBiotech Patheon breaks into drug delivery - Aug 29, 2006 ...a once-daily, extended-release formulation of ciprofloxacin hydrochloride for the treatment of uncomplicated urinary tract infections, and Glumetza, ... OutSourcing-Pharma.com Depomed Initiates Phase 3 Program in Menopausal Hot Flashes - Sep 17, 2008 Proquin(R) XR (ciprofloxacin hydrochloride extended release tablets) is approved in the United States for the once-daily treatment of uncomplicated urinary ... RedOrbit Depomed to Present at the ThinkEquity Partners Growth Conference. - Sep 5, 2006 ProQuin(R) XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary ... Free with registration - Business Wire - AccessMyLibrary.com Solvay Pharmaceuticals, Inc. Announces Exclusive North American … - Nov 20, 2008 Proquin® XR (ciprofloxacin hydrochloride) is approved in the United States for the once-daily treatment of uncomplicated urinary tract infections and is ... International Business Times Depomed To Present at Three Upcoming Conferences - Oct 24, 2008 Proquin ® XR (ciprofloxacin hydrochloride) is approved in the United States for the once-daily treatment of uncomplicated urinary tract infections and is ... International Business Times Daily Market Movers Digest Report for Thursday July 12th, CIPH, DEPO,... - Jul 12, 2007 ProQuin XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary ... Free with registration - M2 Presswire - AccessMyLibrary.com Depomed Initiates Second Phase 3 Trial In Menopausal Hot Flashes - Oct 21, 2008 Proquin® XR (ciprofloxacin hydrochloride) is approved in the United States for the once-daily treatment of uncomplicated urinary tract infections and is ... Medical News Today - Medical News Today (press release) Depomed Elects Karen A. Dawes to Board of Directors - Apr 8, 2008 ProQuin(R) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary ... Genetic Engineering News - Genetic Engineering News (press release) Depomed Announces Presentation of Clinical Data at the North American... - Sep 25, 2008 Proquin(R) XR (ciprofloxacin hydrochloride) is approved in the United States for the once-daily treatment of uncomplicated urinary tract infections and is ... Genetic Engineering News - Genetic Engineering News (press release) Depomed Gains Greater Access to Global Pharmaceutical Companies … - Aug 7, 2006 ProQuin(R) XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary ... Free with registration - Business Wire - AccessMyLibrary.com Depomed Reports Second Quarter 2007 Financial Results - Jun 30, 2007 ProQuin(R) XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary ... Genetic Engineering News - Genetic Engineering News (press release) David Scott Cole, MD - Jun 22, 2005 The first drug is ciprofloxacin hydrochloride (Cipro); the 1997 PDR stated that there could be fetal bone damage with use of this drug during pregnancy. ... Medscape Press Release: Depomed Announces Positive Phase II Results for Once … - Dec 11, 2006 ProQuin® XR (ciprofloxacin hydrochloride) extended-release tablets have been approved by the FDA for the once daily treatment of uncomplicated urinary tract ... FierceBiotech Making sense of drug safety.(COMMENTARY) | Article from The … - Dec 7, 2005 The first paragraph of the first section, "Description," contains this gem: "Ciprofloxacin hydrochloride, USP, a fluoroquinolone, is the monohydrochloride ... Pay-Per-View - Washington Times - HighBeam Research Loislaw Federal District Court Opinions - IN RE TERAZOSIN … - Jan 5, 2005 Id. at 1306 (citing In re Ciprofloxacin Hydrochloride Antitrust Litig., 261 F. Supp. 2d 188, 249 (E.D.N.Y. 2003)). The Eleventh Circuit, therefore, ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw In re Tamoxifen Citrate Antitrust Litigation, 429 F.3d 370 (2d Cir.... - Nov 2, 2005 See In re Ciprofloxacin Hydrochloride Antitrust Litig., 166 F. Supp. ... [116], Like the patent for the compound ciprofloxacin hydrochloride, which was the ... $2.95 - U.S. Court of Appeals, Second Circuit - VersusLaw Brand Names/Synonyms: ciprofloxacin hydrochloride is also known by the following brand names and/or synonymsBacquinor; Baycip; Bernoflox; CIPROFLOXACIN HCL; Ciflox; Cifloxin; Ciloxan; Ciprinol; Cipro; Cipro I.V.; Cipro Xl; Cipro Xr; Ciprobay; Ciprocinol; Ciprodar; Ciprofloxacin; Ciprofloxacin Base; Ciprofloxacin Dihydrochloride; Ciprofloxacin Hydrochloride; Ciprofloxacin Monohydrochloride; Ciprofloxacina; Cipromycin; Ciproquinol; Ciproxan; Ciproxin; Flociprin; Floxin; Floxin Otic; Floxin in Dextrose 5%; Ocuflox; Ofloxacin; Proquin Xr; Septicide; Velomonit Drug Category: ciprofloxacin hydrochloride is categorized under the following by the FDA: Anti-Infectives; Quinolones; ATC:J01MA02; ATC:S01AX13; ATC:S03AA07 Dosage Forms: LIQUID; OINTMENT; SOLUTION; SUSPENSION; TABLET; TABLET (COMBINED RELEASE); TABLET (EXTENDED-RELEASE) Absorption: 70-80% Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1H-quinoline-3-carboxylicacid |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
